Category: Company News

Joint Venture and Patent Grant Mark Jointechlabs’ Entry Into China Regenerative Medicine Microfat Market

Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.

Read more

Jointechlabs Makes Microfat-based Regenerative Medical Procedures More Efficient and Profitable

Jointechlabs has released new components and standardized processing to reduce time, complexity, and cost of microfat-based regenerative medicine procedures.

Read more

MiniTC Adipose System Now Faster, More Convenient, Personalized

New syringes and a choice of cannulas will make adipose processing faster and personalized to each physician’s needs.

Read more

MDSAP Quality Certification Awarded to Jointechlabs

Jointechlabs earned the MDSAP quality certification indicating compliance with ISO13485:2016 for medical device quality management.

Read more

Jointechlabs launches European expansion with new partnerships, grants, and subsidiary

European focus includes a new subsidiary in Austria, a medical research center in partnership with a prominent health center, and development and distribution agreements for Germany, Austria, Switzerland, Italy, Spain, and the Balkans. CHICAGO, OCT. 20, 2022/PRNewswire/–Jointechlabs, Inc., a Regenerative Medicine Solutions company announced a Vienna-based subsidiary named JointechPlus GmbH. They also announced research, development, […]

Read more

Jointechlabs is Granted Additional Patent for Innovations Using Adipose in Regenerative Medicine Applications

Jointechlabs has just strengthened its intellectual property position with the granting of a new US patent covering systems and methods of encapsulating stem cells.

Read more

Jointechlabs’ MiniTC Training by Dr. Nathan Katz, Ph.D., and Dr. Enrico Guarino

Drs. Katz and Guarino demonstrate the operation of MiniTC.

Read more

3D Bioprinting of Autologous Adipose Tissue for Wound Healing

Critical skin wounds are a major cost for the health sector and lead to immense suffering for the patients. One way to facilitate the healing of these wounds is through autologous adipose tissue transplants. However, the implanted tissue needs to be vascularized or it will suffer from necrosis. To combat this Stromal vascular fraction (SVF), […]

Read more

Short Review: Non-cultured Adipose-derived MSCs for Treatment of OA, Jointechlabs, Inc.

Treating patients with OA presents a significant challenge for physicians as no therapies to date have demonstrated efficacy in curing or even halting disease progression. Therefore, most approaches initially target pain management and factors that may be exacerbating stress on the joint. https://dx.doi.org/10.2147%2FSCCAA.S68073 â€“ Mayo Clinic, MN Corticosteroid toxicity for chondrocytes has been long reported, both […]

Read more

Comparison of Different Conditions for the Survival of Human Abdominal Fat in vitro

Katz, N., Koukharenko, V. and Geldner, P2,3. Laboratory of Stem cells and Bioengineering, Jointechlabs, Inc., Skokie, IL North Michigan Surgical Center, Chicago, IL Geldner Center, Chicago, IL Introduction: Fat auto graft transplantation method for different reconstructive plastic surgeries has been fueled recently by encouraging reports from Japan, the United Kingdom, the United States, and others. […]

Read more
Next Page »